Correlation Between COMPUGROUP MEDSPADR and 10X GENOMICS

Can any of the company-specific risk be diversified away by investing in both COMPUGROUP MEDSPADR and 10X GENOMICS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining COMPUGROUP MEDSPADR and 10X GENOMICS into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between COMPUGROUP MEDSPADR 1 and 10X GENOMICS DL, you can compare the effects of market volatilities on COMPUGROUP MEDSPADR and 10X GENOMICS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in COMPUGROUP MEDSPADR with a short position of 10X GENOMICS. Check out your portfolio center. Please also check ongoing floating volatility patterns of COMPUGROUP MEDSPADR and 10X GENOMICS.

Diversification Opportunities for COMPUGROUP MEDSPADR and 10X GENOMICS

-0.19

Correlation Coefficient

COMPUGROUP MEDSPADR  10X GENOMICS

Good diversification

The 3 months correlation between COMPUGROUP and 10X is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding COMPUGROUP MEDSPADR 1 and 10X GENOMICS DL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 10X GENOMICS DL and COMPUGROUP MEDSPADR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on COMPUGROUP MEDSPADR 1 are associated (or correlated) with 10X GENOMICS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 10X GENOMICS DL has no effect on the direction of COMPUGROUP MEDSPADR i.e., COMPUGROUP MEDSPADR and 10X GENOMICS go up and down completely randomly.

Pair Corralation between COMPUGROUP MEDSPADR and 10X GENOMICS

Assuming the 90 days trading horizon COMPUGROUP MEDSPADR 1 is expected to generate 0.35 times more return on investment than 10X GENOMICS. However, COMPUGROUP MEDSPADR 1 is 2.9 times less risky than 10X GENOMICS. It trades about 0.05 of its potential returns per unit of risk. 10X GENOMICS DL is currently generating about -0.1 per unit of risk. If you would invest  2,080  in COMPUGROUP MEDSPADR 1 on December 27, 2024 and sell it today you would earn a total of  100.00  from holding COMPUGROUP MEDSPADR 1 or generate 4.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

COMPUGROUP MEDSPADR 1  vs.  10X GENOMICS DL

COMPUGROUP MEDSPADR

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in COMPUGROUP MEDSPADR 1 are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, COMPUGROUP MEDSPADR is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

10X GENOMICS DL

Risk-Adjusted Performance

Very Weak

Over the last 90 days 10X GENOMICS DL has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with COMPUGROUP MEDSPADR and 10X GENOMICS

The main advantage of trading using opposite COMPUGROUP MEDSPADR and 10X GENOMICS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if COMPUGROUP MEDSPADR position performs unexpectedly, 10X GENOMICS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 10X GENOMICS will offset losses from the drop in 10X GENOMICS's long position.

The idea behind COMPUGROUP MEDSPADR 1 and 10X GENOMICS DL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.